News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

Cameraman filming movie
By Jennifer Maas, Variety | 03.22.2024

“We Were Dangerous” is a surprisingly funny film for a movie whose central conflict is the sterilization of...

Kidney surgery operating room
By Rob Stein, NPR | 03.21.2024

For the first time, surgeons have transplanted a kidney from a genetically modified pig into a living person, doctors in...

Gene therapy costs graphic
By Antonio Regalado, MIT Technology Review | 03.20.2024

There is a new most expensive drug ever—a gene therapy that costs as much as a Brooklyn brownstone or a...

Mexican Flag
By Carey Gillan, UnSpun | 03.18.2024

A Mexican standoff with the United States turned into a Mexican smack-down this month with the release of Mexico’s formal...

DNA wheel
By Sarah Zhang, The Atlantic | 03.18.2024

People are discovering the truth about their biological parents with DNA—and learning that incest is far more common than many...

CRISPR gene editing visual
By Mariella Bodemeier Loayza Careaga, The Scientist | 03.15.2024

Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.

Humans are never...

Crispr
By Hannah Thomasy, The Scientist | 03.15.2024

Today, Massachusetts Institute of Technology biologist Kevin Esvelt is well known for his work on guided evolution technologies—creating systems for ...

Crispr
By Nick Paul Taylor, BioSpace | 03.14.2024

A U.K. watchdog balked at the cost-effectiveness of Vertex Pharmaceuticals’ CRISPR-based sickle cell disease therapy Thursday, recommending against funding...